Precision medicine is facing a critical transition driven by the growing complexity of biological data and the insufficient ability of current models to translate such data into clinically meaningful information. Linear, single-gene approaches are no longer adequate to explain the multifactorial nature of most modern diseases, whose phenotypes emerge from combinations of genetic, molecular, and environmental factors. Network-based precision medicine addresses this by providing a systemic framework capable of integrating heterogeneous omics data, interactomes, and clinical information to identify disease modules and novel therapeutic opportunities. The distinct novelty of this review is its focus on the potential of “network language” as the primary driver for realizing precision medicine through professional collaboration. We argue that networks are not merely tools that achieve precision “per se”; rather, their transformative power lies in their ability to serve as a shared and interpretable interface grounded in network theory. By offering this common conceptual ground, the paradigm bridges the deep cultural and methodological gaps between clinicians and data analysts, enabling effective cooperation between figures with fundamentally different, and often divergent, backgrounds. Practical tools—such as biological network analysis and Molecular Tumor Boards—demonstrate how computational modeling and clinical expertise can be successfully combined to generate actionable insights. Ultimately, network-based precision medicine represents a decisive step toward reconstructing the patient’s complexity and promoting a genuinely personalized clinical approach in which quantitative analysis and medical reasoning act synergistically through multidisciplinary integration.
Palumbo et al. (2026) studied this question.